Drug dependent insomnia
Conditions
Interventions
Sponsors
Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1, Diagonized (by Traditional Chinese medicine and modern medicine) as insomina and drug dependent insomnia, taking Estazolam 1-2mg (per day) over 6 months, right-handed; 2, being conscious, without aphasia and other distrubance of intelligence, being able to understand questions in scales and cooperate with the treatment; 3, scoring 7 or more on the Pittsburgh Sleep Quality Index; 4, without severe physical or mental diseases (e.g., cordio-vascular diseases, kidney deficiencies, etc.); 5. in the age of 40 to 65, being willing to accept and comply with the treatment; 6, taking part voluntarily with signature on the informed consent; 7, scoring from 7 to 21 on HAMA; 8, scoring more than 7 and less than or equal to 17 on HAMD.
Exclusion criteria
Exclusion criteria: 1. Taking medicine other than Estazolam in treating insomnia; 2. with insomnia induced by (other) medicines, emergencies, ill habits, and/or other environmental/phychological factors; 3. with insomnia induced by severe neurasthenia,stress disorder,personality disorder, other physical diseases and/or psychoactive substances; 4. judged by the researcher(s) as having other conditions which may interfere with the conduct of research (e.g., patients whose working conditions change frequently or who travel frequently); 5. being pregnant, being in lactation, with ??, and/or with ??????; 6. with severe liver and/or kidney deficiencies, and/or ?????????; 7. with alcoholism and/or other substance-dependencies; 8. being unable to comply with the treatment due to any external reasons; 9. being allergic to rubbing alcohol and/or acupuncture; 10. being in conditions which may interfere with abdominal acupuncture (i.e., diseases in abdominal organs, scars on abdomen, etc.); 11. Taking any other treatment and/or clinical research currently. Patients who have one or more conditions listed above are not qualified as subjects of this research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| estazolem intake;rate of estazolem reduction;Pittsburgh sleep quality index; | — |
Secondary
| Measure | Time frame |
|---|---|
| HAMA;BWSQ;assessment of safety;EEG;HAMD; | — |
Countries
China
Contacts
Public ContactWang Jing
Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine
Outcome results
None listed